{
    "SPADE_N_04498": {
        "Clinical Information": [],
        "Patent Information": [
            {
                "Patent No": "US 2012/0308638 A1",
                "Patent Link": "http://www.lens.org/lens/patent/US_2012_0308638_A1",
                "Patent Type": "Patent Application",
                "Publication Date": "2012-12-6",
                "Family Info": "EP2513139A1,WO2011073663A1",
                "Patent Title": "Antimicrobial peptides.",
                "Abstract": "The present invention provides novel therapeutic antimicrobial peptides that are bactericides and have an inhibitory effect on biofilms produced by biofilm-forming bacteria and especially biofilm-forming staphyloccocal bacteria. The invention includes the nucleic acids encoding the polypeptides, methods of treating bacterial infections, medical devices or implants or prosthetics impregnated with, covered or coated in the polypeptides, and means of delivery of the peptide to the oral cavity."
            },
            {
                "Patent No": "US 2023/0416797 A1",
                "Patent Link": "http://www.lens.org/lens/patent/US_2023_0416797_A1",
                "Patent Type": "Patent Application",
                "Publication Date": "2023-12-28",
                "Family Info": "JP2023548477A,EP4243844A1,CN116685204A,WO2022104321A1",
                "Patent Title": "MODULATING ANTIMICROBIAL PEPTIDE HALF-LIFE",
                "Abstract": "Methods of modulating the half-life of an antimicrobial peptide are described. The method may include administering an antimicrobial peptide to an environment where the antimicrobial peptide remains active until a specified endpoint, and on or after the specified endpoint, digesting the antimicrobial peptide with a protease to thereby inactivate the antimicrobial peptide and modulate its half-life. Compositions and kits for modulating the half-life of an antimicrobial peptide are also described."
            }
        ],
        "Sequence Information": {
            "SPADE ID": "SPADE_N_04498",
            "Sequence": "MAGFLKVVQLLAKYGSKAVQWAWANKGKILDWLNAGQAIDWVVSKIKQILGIK",
            "Sequence Length": 53,
            "Peptide Name": "Sequence 5 from Patent US 20120308638",
            "Source": "Lactococcus lactis QU 5",
            "Biological Activity": [
                "Antimicrobial"
            ],
            "Frequent Amino Acids": "KAL",
            "Absent Amino Acids": "CEHOPRTU",
            "Basic Residues": 8,
            "Acidic Residues": 2,
            "Hydrophobic Residues": 30,
            "Polar Residues": 29,
            "Positive Residues": 8,
            "Negative Residues": 2,
            "Mass": 5898.02,
            "PI": 10.1,
            "Net Charge": 6,
            "Hydrophobicity": 0.3,
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_N_00054",
                    "Similarity": 1.0,
                    "Sequence": "AGFLKVVQLLAKYGSKAVQWAWANKGKILDWLNAGQAIDWVVSKIKQILGIK"
                },
                {
                    "SPADE_ID": "SPADE_N_00217",
                    "Similarity": 0.9433962264150944,
                    "Sequence": "MAGFLKVVQILAKYGSKAVQWAWANKGKILDWINAGQAIDWVVEKIKQILGIK"
                }
            ]
        }
    }
}